The PMP22 gene helps build and maintain the insulating covering around nerves outside the brain and spinal cord, so signals travel smoothly to muscles and skin. This gene plays an important role in keeping nerve messages steady during movement and sensation. If PMP22 is missing, extra copies are present, or a disease-causing variant changes how it works, people may develop inherited nerve conditions with weakness, foot problems, numbness, tingling, or repeated nerve pressure injuries. Examples include Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies.
What is a gene?
A gene is a section of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes hold the instructions for making proteins, the parts of cells that do the work. Other genes mainly help control when certain processes happen, where they happen, and how strongly they are carried out. Taken together, genes influence how the body develops and functions, and they can affect how you respond to food, stress, or medications. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
PMP22Gene function
What if the gene works
Your peripheral nerves rely on the PMP22 gene to help build and maintain myelin, the insulating covering around nerves. This helps signals travel smoothly between the brain, spinal cord, and muscles or skin.
Risk
What if the gene does not work
Changes in the PMP22 gene can disrupt peripheral nerve covering, causing inherited neuropathies with numbness, tingling, weakness, and balance problems. Effects range from brief pressure palsies to slowly progressive Charcot-Marie-Tooth disease, and more severe variants may cause earlier symptoms.
Treatment
What does that mean for your treatment
No PMP22-specific treatment or drug choice is currently established in clinical guidelines; care is supportive and may include physical therapy, braces, pain treatment, and reducing pressure on vulnerable nerves. The PMP22 gene is also being studied as a drug target, especially through treatments designed to lower PMP22 activity in Charcot-Marie-Tooth disease type 1A.
Conditions associated with PMP22
Gene function
What if the gene works
Your peripheral nerves need the PMP22 gene to stay well insulated and send signals smoothly. This gene is most active in Schwann cells, the cells that wrap nerves in a protective coating called myelin. Understanding what the PMP22 gene does in peripheral nerves helps show how your body supports everyday movement and sensation.
In peripheral nerves, the PMP22 gene helps Schwann cells build the myelin coating around nerve fibers. This coating works like insulation, helping signals travel in a more steady and organized way.
PMP22 also helps keep the myelin layer compact and stable over time. That steady structure supports clear communication between the brain, spinal cord, muscles, and skin.
This gene helps guide normal Schwann cell growth and maturity. By supporting these nerve-supporting cells, it helps with the routine upkeep of peripheral nerves.
What is a variant?
Within a gene, a genetic variant is a small difference in the DNA sequence. Variants are common and help explain normal human diversity, such as variation in appearance, metabolism, and the body’s response to environmental influences. Many have no noticeable effect at all and are simply part of natural genetic variation. In some situations, though, a variant changes gene function more strongly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the PMP22 gene can change how much PMP22 protein cells make or whether the protein folds and moves correctly in myelin forming cells. Some PMP22 gene variants cause a mild drop or rise in protein levels, while more severe variants can trap the protein inside the cell or add or remove a gene copy, which disrupts the protective coating around nerves. This range often influences whether nerve problems are milder or begin earlier and affect more nerves.
How variants are linked to conditions
Variants of the PMP22 gene are linked to several inherited nerve conditions. A duplication involving the PMP22 gene causes Charcot-Marie-Tooth disease type 1A, while a deletion involving the PMP22 gene causes hereditary neuropathy with liability to pressure palsies. Other disease-causing variants in the PMP22 gene can lead to related peripheral neuropathies, including Charcot-Marie-Tooth disease type 1E. These findings can confirm a genetic diagnosis rather than simply showing a higher risk.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology and are widely seen across the general population. Most do not directly affect health and simply reflect normal human variation. In many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences also play a role. In some situations, though, one well understood variant in a particular gene is enough to establish a diagnosis.
Are there things that can increase or change my risk?
For PMP22, the gene change itself is the main reason risk is high, so lifestyle steps do not remove that inherited risk. In some people, especially those living with pressure-sensitive nerve problems, long pressure on nerves, repeated strain, or certain medicines that can harm nerves may make symptoms more likely or worse. Regular follow-up can help catch problems early.
Inheritance of PMP22 variants
The inheritance pattern for PMP22-related conditions can differ depending on the specific condition and variant. Many well-known PMP22-related neuropathies, including Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies, follow an autosomal dominant pattern, so a parent carrying the variant can pass it to a son or daughter with a 50% chance in each pregnancy. Some rarer PMP22-related conditions are autosomal recessive, which means a child inherits one altered copy from each parent.
What does my PMP22 result mean for my family?
For many PMP22 results, close relatives can also carry the same gene change, so parents, brothers, sisters, and children may have it too. In families with the more common PMP22-related nerve conditions, each child of someone with the variant has a 1 in 2, or 50%, chance of inheriting it, although some cases happen for the first time in one person. PMP22 is also linked to rarer conditions with a different family pattern, so what it means for relatives depends on the exact result.
Genetic information
Genetic testing
How you find out about variants
PMP22 genetic testing checks a blood or saliva sample for extra copies, missing copies, or small variants in the PMP22 gene. Labs often look for copy number changes first, then use DNA sequencing for smaller changes if needed. Results can show whether a PMP22 variant is linked to symptoms and may run in a family.
When should I consider getting a genetic test?
Genetic testing for the PMP22 gene can be worth considering if there is a personal or family history of inherited nerve problems, such as slowly worsening foot weakness, high arches, numbness, or repeated episodes of weakness after pressure on a nerve. It can help confirm Charcot-Marie-Tooth disease or an inherited tendency for nerves to be unusually sensitive to pressure.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and the kind of variant involved. Over time, many factors shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information adds context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles medicines, so the same treatment may work differently from one person to another. Some people break down a drug more slowly or more quickly, while others may be more sensitive to its effects. This kind of variation is common and can influence how well a medicine works or the chance of side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medicines. By looking at links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medications, genes can shape how strongly a drug works or how the body handles it. This information can support treatment decisions that are both more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the PMP22 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so questions about medicines or side effects are best discussed with your doctor. For people living with PMP22-related nerve conditions, clinicians may still review medicines that can affect the nerves, because some have been reported to worsen numbness, tingling, or weakness.
History
PMP22 became historically important when researchers linked changes on chromosome 17 to inherited nerve conditions such as Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies. In the early 1990s, scientists showed that having an extra copy or a missing copy of the PMP22 gene could explain why these conditions run in families. This was a major step because it made gene dosage, meaning too much or too little gene material, a clear cause of disease in human genetics. From these first observations, research expanded steadily. Genetic testing for PMP22 later became a key part of evaluating people with long-standing numbness, weakness, or repeated nerve pressure injuries. The gene’s history helped turn inherited neuropathy from a mainly descriptive diagnosis into one that could be confirmed at the DNA level.